Donafenib yields survival advantage over sorafenib in Chinese patients with advanced liver cancer

Press/Media

Period	14 Jul 2021

Media coverage

Title	Donafenib yields survival advantage over sorafenib in Chinese patients with advanced liver cancer
Media name/outlet	MDAlert.com
Country/Territory	United States
Date	14/07/21
URL	https://www.mdalert.com/news/article/donafenib-yields-survival-advantage-over-sorafenib-in-chinese-patients-with-advanced-liver-cancer
Persons	Augusto Villanueva Rodriguez